{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:44:42Z","timestamp":1793943882259,"version":"4.8.0"},"reference-count":273,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The hypoxic microenvironment, characterized by significantly reduced oxygen levels within tissues, has emerged as a critical factor in the pathogenesis and progression of various autoimmune diseases (AIDs). Central to this process is the hypoxia-inducible factor-1 (HIF-1), which orchestrates a wide array of cellular responses under low oxygen conditions. This review delves into the multifaceted roles of the hypoxic microenvironment in modulating immune cell function, particularly highlighting its impact on immune activation, metabolic reprogramming, and angiogenesis. Specific focus is given to the mechanisms by which hypoxia contributes to the development and exacerbation of diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), multiple sclerosis (MS), and dermatomyositis (DM). In these conditions, the hypoxic microenvironment not only disrupts immune tolerance but also enhances inflammatory responses and promotes tissue damage. The review also discusses emerging therapeutic strategies aimed at targeting the hypoxic pathways, including the application of HIF-1\u03b1 inhibitors, mTOR inhibitors, and other modulators of the hypoxic response. By providing a comprehensive overview of the interplay between hypoxia and immune dysfunction in AIDs, this review offers new perspectives on the underlying mechanisms of these diseases and highlights potential avenues for therapeutic intervention.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1435306","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T06:11:38Z","timestamp":1730959898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["The role of hypoxic microenvironment in autoimmune diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Xun","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Yin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An updated advance of autoantibodies in autoimmune diseases","volume":"20","author":"Xiao","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu","article-title":"Identification and characterization of post-activated B cells in systemic autoimmune diseases","volume":"10","author":"WS","year":"2019","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.002","article-title":"Autoimmune diseases and their relation with immunological, neurological and endocrinological axes","volume":"16","author":"Coronel-Restrepo","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1073971","article-title":"Emerging role of hypoxia-inducible factor-1\u03b1 in inflammatory autoimmune diseases: A comprehensive review","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28114413","article-title":"Chronic inflammation\u2019s transformation to cancer: A nanotherapeutic paradigm","volume":"28","author":"Sohrab","year":"2023","journal-title":"Molecules."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01668","article-title":"Hypoxia-inducible factor is critical for pathogenesis and regulation of immune cell functions in rheumatoid arthritis","volume":"11","author":"Xin","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113068","article-title":"Hypoxia, a key factor in the immune microenvironment","volume":"151","author":"Hu","year":"2022","journal-title":"BioMed Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4375120","article-title":"Parallel aspects of the microenvironment in cancer and autoimmune disease","volume":"2016","author":"Rahat","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318345110","article-title":"Hypoxia and inflammation are two sides of the same coin","volume":"110","author":"Bartels","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385936","article-title":"Editorial: Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1249500","article-title":"Novel and potential future therapeutic options in systemic autoimmune diseases","volume":"15","author":"Balogh","year":"2024","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1150661","article-title":"Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases","volume":"14","author":"Zhiyong","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1323486","article-title":"Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases","volume":"14","author":"Lan","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.13.5680","article-title":"Hypoxia-inducible nuclear factors bind to an enhancer element located 3\u2019 to the human erythropoietin gene","volume":"88","author":"Semenza","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.14.6496","article-title":"Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3\u2019 enhancer","volume":"91","author":"Firth","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 \u03b1","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00011","article-title":"Hypoxia-inducible factors (HIFs) and phosphorylation: impact on stability, localization, and transactivity","volume":"4","author":"Kietzmann","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.34479","article-title":"Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis","volume":"64","author":"Muz","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.8b08785","article-title":"Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite\/ceria co-decorated nanoparticles for rheumatoid arthritis treatment","volume":"13","author":"Kim","year":"2019","journal-title":"ACS Nano."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.08.026","article-title":"Recruitment of HIF-1\u03b1 and HIF-2\u03b1 to common target genes is differentially regulated in neuroblastoma: HIF-2\u03b1 promotes an aggressive phenotype","volume":"10","author":"Holmquist-Mengelbier","year":"2006","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010035","article-title":"VHL and hypoxia signaling: beyond HIF in cancer","volume":"6","author":"Zhang","year":"2018","journal-title":"Biomedicines."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R115.662627","article-title":"Protein hydroxylation catalyzed by 2-oxoglutarate-dependent oxygenases","volume":"290","author":"Markolovic","year":"2015","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2005.12.012","article-title":"Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1\u03b1 stabilization","volume":"40","author":"Kohl","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2012.9","article-title":"The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity","volume":"13","author":"Masson","year":"2012","journal-title":"EMBO Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15371","article-title":"Alpinetin inhibits breast cancer growth by ROS\/NF-\u03baB\/HIF-1\u03b1 axis","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000329","article-title":"PI3King the lock: targeting the PI3K\/Akt\/mTOR pathway as a novel therapeutic strategy in neuroblastoma","volume":"37","author":"King","year":"2015","journal-title":"J Pediatr hematology\/oncology."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9219847","article-title":"Proximal tubular development is impaired with downregulation of MAPK\/ERK signaling, HIF-1\u03b1, and catalase by hyperoxia exposure in neonatal rats","volume":"2019","author":"Xu","year":"2019","journal-title":"Oxid Med Cell Longevity."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150712778","article-title":"Cordycepin down-regulates multiple drug resistant (MDR)\/HIF-1\u03b1 through regulating AMPK\/mTORC1 signaling in GBC-SD gallbladder cancer cells","volume":"15","author":"Wu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.884881","article-title":"Suppression of NLRP3 inflammasome by dihydroarteannuin via the HIF-1\u03b1 and JAK3\/STAT3 signaling pathway contributes to attenuation of collagen-induced arthritis in mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1749436","article-title":"Inhibiting interleukin-6\/signal transducers and activators of transduction-3\/hypoxia-inducible factor-1\u03b1 Signaling pathway suppressed the growth of infantile hemangioma","volume":"33","author":"Maimaiti","year":"2023","journal-title":"Eur J Pediatr Surg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2013.02.001","article-title":"Mechanisms of regulatory T cell counter-regulation by innate immunity","volume":"27","author":"Yeh","year":"2013","journal-title":"Transplant Rev (Orlando)."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888719","article-title":"IL-17 induces autophagy dysfunction to promote inflammatory cell death and fibrosis in keloid fibroblasts via the STAT3 and HIF-1\u03b1Dependent signaling pathways","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1038\/s41598-021-98651-z","article-title":"TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A","volume":"11","author":"Koedderitzsch","year":"2021","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106570","article-title":"Cinnamaldehyde suppresses NLRP3 derived IL-1beta via activating succinate\/HIF-1 in rheumatoid arthritis rats","volume":"84","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbrc.2015.04.119","article-title":"SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) via direct interactions during hypoxia","volume":"462","author":"Joo","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/1535370218759636","article-title":"Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells","volume":"243","author":"Hsu","year":"2018","journal-title":"Exp Biol Med (Maywood)."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.520734","article-title":"Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation","volume":"289","author":"Hong","year":"2014","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41419-020-03372-2","article-title":"SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1\u03b1 and reactive oxygen species","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1024\/0300-9831\/a000159","article-title":"HIF1-alpha-mediated gene expression induced by vitamin B1 deficiency","volume":"83","author":"Sweet","year":"2013","journal-title":"Int J Vitam Nutr Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-007-9086-x","article-title":"The Warburg effect and its cancer therapeutic implications","volume":"39","author":"Zhao","year":"2007","journal-title":"J bioenergetics biomembranes."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899735","article-title":"Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival","volume":"37","author":"Pathria G","year":"2018","journal-title":"EMBO J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S207560","article-title":"ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1\u03b1 signaling pathways","volume":"12","author":"Shen","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4566851","article-title":"The ROS\/GRK2\/HIF-1\u03b1\/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes and the regulation of monomer derivatives of paeoniflorin","volume":"2022","author":"Hong","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1038\/s41467-024-51207-x","article-title":"Immunometabolic effects of lactate on humoral immunity in healthy individuals of different ages","volume":"15","author":"Romero","year":"2024","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25524-3","article-title":"Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1\u03b1 inhibition","volume":"8","author":"Siddiqui","year":"2018","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1\u2013mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"ShihChin","year":"2014","journal-title":"Sci (New York NY)."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416142","article-title":"mTOR signaling network in cell biology and human disease","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2015.30.10.1429","article-title":"Baseline characteristics of the korean registry of pulmonary arterial hypertension","volume":"30","author":"Chung WJ","year":"2015","journal-title":"J Korean Med Science."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119242","article-title":"MARK2\/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPK\u03b11\/mTOR\/HIF-1\u03b1 signaling pathway","volume":"1869","author":"Raj","year":"2022","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649693","article-title":"Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different MO","volume":"12","author":"Fresneda Alarcon","year":"2021","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2012.727991","article-title":"Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis","volume":"46","author":"Kundu","year":"2012","journal-title":"Free Radic Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584116","article-title":"Rheumatoid arthritis synovial fluid neutrophils drive inflammation through production of chemokines, reactive oxygen species, and neutrophil extracellular traps","volume":"11","author":"Wright","year":"2021","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324186","article-title":"Activation of hypoxia-inducible factor-1\u03b1 (Hif-1\u03b1) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model","volume":"118","author":"Elks","year":"2011","journal-title":"Blood."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2017.01.018","article-title":"Differential reactive oxygen species production of neutrophils and their oxidative damage in patients with active and inactive systemic lupus erythematosus","volume":"184","author":"Elloumi","year":"2017","journal-title":"Immunol Letters."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0564","article-title":"Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases","volume":"105","author":"Scapini","year":"2005","journal-title":"Blood."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138065","article-title":"Changes in expression of membrane TNF, NF-kappaB activation and neutrophil apoptosis during active and resolved inflammation","volume":"70","author":"Wright","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12970","article-title":"Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production","volume":"189","author":"Mitchell","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00395-021-00904-5","article-title":"Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation","volume":"116","author":"Chang","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2020.102044","article-title":"Activation of hypoxia-inducible factor 1 (Hif-1) enhanced bactericidal effects of macrophages to Mycobacterium tuberculosis","volume":"126","author":"Li","year":"2021","journal-title":"Tuberculosis (Edinb)."},{"key":"B71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2019.03.015","article-title":"G","volume":"452","author":"Wang SL","year":"2019","journal-title":"Metab reprogramming macrophages during infections cancer. Cancer Letters."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.06.003","article-title":"Myeloid PHD2 deficiency accelerates neointima formation via Hif-1\u03b1","author":"Christoph","year":"2022","journal-title":"Mol Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7516","article-title":"Cutting edge: Essential role of hypoxia inducible factor-1\u03b1 in development of lipopolysaccharide-induced sepsis","volume":"178","author":"Peyssonnaux","year":"2007","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.08.054","article-title":"An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1\u03b1\/NF-\u03baB cascade regulation of ROS scavenging and macrophage repolarization","volume":"152","author":"Li","year":"2022","journal-title":"Acta Biomaterialia."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.immuni.2019.01.021.","article-title":"CCR7 chemokine receptor-inducible lnc-dpf3 restrains dendritic cell migration by inhibiting HIF-1\u03b1-mediated glycolysis","volume":"50","author":"Liu","year":"2019","journal-title":"Immunity."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24666","article-title":"Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1\u03b1 and PI3K\/Akt pathway","volume":"229","author":"Filippi","year":"2014","journal-title":"J Cell Physiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1038\/s41598-021-84916-0","article-title":"STAT3 governs the HIF-1\u03b1 response in IL-15 primed human NK cells","volume":"11","author":"Coulibaly","year":"2021","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.67","article-title":"Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis","volume":"9","author":"Fl\u00fcck","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1515\/hsz-2012-0320","article-title":"Role of hypoxia inducible factor-1\u03b1 for interferon synthesis in mouse dendritic cells","volume":"394","author":"Regina","year":"2013","journal-title":"Biol Chem"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-018-21891-z","article-title":"HIF-1\u03b1 hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis","volume":"8","author":"Hammami","year":"2018","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2015.08.036","article-title":"Hypoxia-inducible factor 1\u03b1 modulates metabolic activity and cytokine release in anti-Aspergillus fumigatus immune responses initiated by human dendritic cells","volume":"305","author":"Fliesser","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-021-03126-9","article-title":"Hypoxia-inducible factor-1 \u03b1 expression is induced by IL-2 via the PI3K\/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells","volume":"71","author":"Cluff","year":"2022","journal-title":"Cancer Immunol Immunother."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68484","article-title":"HIF1\u03b1 is required for NK cell metabolic adaptation during virus infection","volume":"10","author":"Victorino","year":"2021","journal-title":"Elife."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0772-8","article-title":"Dynamic regulation of hypoxia-inducible factor-1\u03b1 activity is essential for normal B cell development","volume":"21","author":"Burrows","year":"2020","journal-title":"Nat Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1082154","article-title":"Oxygen level is a critical regulator of human B cell differentiation and IgG class switch recombination","volume":"13","author":"Koers","year":"2022","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"367:104409","DOI":"10.1016\/j.cellimm.2021.104409","article-title":"Regulation of humoral immune response by HIF-1\u03b1-dependent metabolic reprogramming of the germinal center reaction","author":"Li","year":"2021","journal-title":"Cell Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease","volume":"9","author":"Meng","year":"2018","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8349-8","article-title":"Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function","volume":"55","author":"McNamee","year":"2013","journal-title":"Immunologic Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043073","article-title":"Relationship between hypoxic and immune pathways activation in the progression of neuroinflammation: role of HIF-1\u03b1 and Th17 cells","volume":"24","author":"Arias","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"eadk1045","DOI":"10.1126\/sciadv.adk1045","article-title":"Sphingolipid biosynthesis is essential for metabolic rewiring during TH17 cell differentiation","volume":"10","author":"Abimannan","year":"2024","journal-title":"Sci Adv"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306171","article-title":"Deficiency of HIF1\u03b1 in antigen-presenting cells aggravates atherosclerosis and type 1 T-helper cell responses in mice","volume":"35","author":"Chaudhari","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948111","article-title":"MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 \u03b1 in experimental autoimmune encephalomyelitis","volume":"49","author":"Wan","year":"2019","journal-title":"Eur J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00436-16","article-title":"Transcription factor KLF2 in dendritic cells downregulates th2 programming via the HIF-1\u03b1\/jagged2\/notch axis","volume":"7","author":"Xiong","year":"2016","journal-title":"mBio."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.7150\/thno.44961","article-title":"HDAC6-specific inhibitor suppresses Th17 cell function via the HIF-1\u03b1 pathway in acute lung allograft rejection in mice","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110278","article-title":"HIF1\u03b1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s42003-021-02721-x","article-title":"Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73","volume":"4","author":"Jarvis","year":"2021","journal-title":"Commun Biol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121326","article-title":"Radioactive nano-oxygen generator enhance anti-tumor radio-immunotherapy by regulating tumor microenvironment and reducing proliferation","volume":"280","author":"Pei","year":"2022","journal-title":"Biomaterials."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00874-1","article-title":"The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription","volume":"19","author":"Hisada","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02776","article-title":"The yin and yang of myeloid derived suppressor cells","volume":"9","author":"Snehil","year":"2018","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030561","article-title":"Myeloid-derived suppressor cells as a therapeutic target for cancer","volume":"9","author":"Law","year":"2020","journal-title":"Cells."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28303","article-title":"Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more","volume":"13","author":"Masahiko","year":"2022","journal-title":"Oncotarget."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J Autoimmunity."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1159\/000489830","article-title":"Myeloid-derived suppressor cells in infection: A general overview","volume":"10","author":"Medina E","year":"2018","journal-title":"J innate Immun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638841","article-title":"Interaction between MDSC and NK cells in solid and hematological Malignancies: impact on HSCT","volume":"12","author":"Nicola","year":"2021","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth C","year":"2019","journal-title":"Br J cancer."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3633-6_15","article-title":"Measurement of metabolic alteration in immune cells under hypoxia","volume":"2755","author":"Fujii","year":"2024","journal-title":"Methods Mol Biol (Clifton NJ)."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI174051","article-title":"Granulocytic myeloid-derived suppressor cell activity during biofilm infection is regulated by a glycolysis-HIF1a axis","volume":"134","author":"Horn","year":"2024","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/JLB.4RI0820-535R","article-title":"Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets","volume":"110","author":"Lovis","year":"2020","journal-title":"J leukocyte Biol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/ijms20020238","article-title":"HIF-1-dependent reprogramming of glucose metabolic pathway of cancer cells and its therapeutic significance","volume":"20","author":"Nagao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu DK","year":"2017","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1320011","article-title":"CD39\/CD73 upregulation on myeloid-derived suppressor cells via TGF-\u03b2-mTOR-HIF-1 signaling in patients with non-small cell lung cancer","volume":"6","author":"Jieyao","year":"2017","journal-title":"Oncoimmunology."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e2302508","DOI":"10.1002\/adma.202302508","article-title":"Augmenting immunogenic cell death and alleviating myeloid-derived suppressor cells by sono-activatable semiconducting polymer nanopartners for immunotherapy","volume":"35","author":"Mengbin","year":"2023","journal-title":"Advanced materials (Deerfield Beach Fla)."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01099","article-title":"Myeloid-derived suppressor cells: not only in tumor immunity","volume":"10","author":"Graham","year":"2019","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int Immunopharmacology."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00949","article-title":"Myeloid-derived suppressor cells: ductile targets in disease","volume":"10","author":"Maria","year":"2019","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401144","article-title":"Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments","volume":"194","author":"Blidner","year":"2015","journal-title":"J Immunol (Baltimore Md: 1950)."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1021612","article-title":"Myeloid-derived suppressor cell: A crucial player in autoimmune diseases","volume":"13","author":"Dandan","year":"2022","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-021-00846-3","article-title":"Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target","volume":"29","author":"Ehsan","year":"2021","journal-title":"Inflammopharmacology."},{"key":"B122","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann Intern Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.961708","article-title":"Metabolomics in rheumatoid arthritis: Advances and review","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia\u2013a key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01636-5","article-title":"A novel mechanism for inhibiting proliferation of rheumatoid arthritis fibroblast-like synoviocytes: geniposide suppresses HIF-1\u03b1 accumulation in the hypoxic microenvironment of synovium","volume":"71","author":"Gan","year":"2022","journal-title":"Inflammation Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","article-title":"Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications","volume":"18","author":"Fearon","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken086","article-title":"Role of hypoxia-inducible factor-1\u03b1 in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes","volume":"47","author":"Ahn","year":"2008","journal-title":"Rheumatol (Oxford)."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001881","article-title":"Hypoxia-inducible factor-2\u03b1 is an essential catabolic regulator of inflammatory rheumatoid arthritis","volume":"12","author":"Ryu","year":"2014","journal-title":"PloS Biol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-012-1463-z","article-title":"PI3 kinase\/Akt\/HIF-1\u03b1 pathway is associated with hypoxia-induced epithelial\u2013mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis","volume":"372","author":"Li","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.08.018","article-title":"Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-kappaB\/HIF-1\u03b1 pathway","volume":"53","author":"Li","year":"2013","journal-title":"Mol Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molimm.2021.12.004","article-title":"STAT3\/HIF-1\u03b1\/fascin-1 axis promotes RA FLSs migration and invasion ability under hypoxia","volume":"142","author":"Yang","year":"2022","journal-title":"Mol Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/art.41748","article-title":"Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis","volume":"73","author":"Chen","year":"202","journal-title":"Arthritis Rheumatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/art.10520","article-title":"Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts","volume":"46","author":"Hitchon","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.341","article-title":"Vascular permeability factor\/endothelial growth factor (VPF\/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue","volume":"180","author":"Fava","year":"1994","journal-title":"J Exp Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109095","article-title":"Advance in bone destruction participated by JAK\/STAT in rheumatoid arthritis and therapeutic effect of JAK\/STAT inhibitors","volume":"111","author":"Ling","year":"2022","journal-title":"Int Immunopharmacology."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-162230","article-title":"Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4","volume":"24","author":"Knowles","year":"2010","journal-title":"FASEB J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109524","article-title":"Angiopoietin-like 4 is over-expressed in rheumatoid arthritis patients: association with pathological bone resorption","volume":"9","author":"Swales","year":"2014","journal-title":"PloS One"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20182431","article-title":"IL-38 restrains inflammatory response of collagen-induced arthritis in rats via SIRT1\/HIF-1\u03b1 signaling pathway","volume":"40","author":"Pei","year":"2020","journal-title":"Biosci Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1302\/2046-3758.122.BJR-2022-0269.R1","article-title":"Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS\/MAPK\/FOXO\/HIF-1 signal pathway in the treatment of rheumatoid arthritis","volume":"12","author":"Li","year":"2023","journal-title":"Bone Joint Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-023-01499-0","article-title":"Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms","volume":"8","author":"Jia","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B143","doi-asserted-by":"publisher","first-page":"ard","DOI":"10.1136\/ard-2023-224491","article-title":"Expression of HIF1\u03b1 in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery","volume":"19","author":"Lyu","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-222021","article-title":"Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go","volume":"81","author":"Nemeth","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B147","doi-asserted-by":"publisher","first-page":"110:108966","DOI":"10.1016\/j.intimp.2022.108966","article-title":"Clinical predictive model to estimate probability of remission in patients with lupus nephritis","author":"Kang","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.008","article-title":"The role of hypoxia in the pathogenesis of lupus nephritis","volume":"98","author":"Kurata","year":"2020","journal-title":"Kidney Int"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002084","article-title":"Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases","volume":"21","author":"Blanco","year":"2023","journal-title":"PloS Biol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.02.019","article-title":"HIF-1\u03b1 and miR-210 differential and lineage-specific expression in systemic lupus erythematosus","volume":"133","author":"Garchow","year":"2021","journal-title":"Mol Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.2174\/1566524022666220114145220","article-title":"Association of circulating levels of hypoxia-inducible factor-1\u03b1 and miR-210 with photosensitivity in systemic lupus erythematosus patients","volume":"23","author":"Gamal-Eldeen","year":"2023","journal-title":"Curr Mol Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180076","article-title":"Mechanisms underlying sex differences in autoimmunity","volume":"134","author":"Fairweather","year":"2024","journal-title":"J Clin Invest"},{"key":"B154","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41591-018-0254-9","article-title":"A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate","volume":"25","author":"Caielli","year":"2019","journal-title":"Nat Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400044","article-title":"Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis","volume":"193","author":"Kshirsagar","year":"2014","journal-title":"J Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175823","article-title":"Luteolin attenuates lupus nephritis by regulating macrophage oxidative stress via HIF-1\u03b1 pathway","volume":"953","author":"Ding","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1620","article-title":"Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis","volume":"12","author":"Chen","year":"2020","journal-title":"Sci Transl Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"274fs5","DOI":"10.1126\/scitranslmed.aaa6731","article-title":"Targeting metabolism for lupus therapy","volume":"7","author":"Mehta","year":"2015","journal-title":"Sci Transl Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41581-020-0303-8","article-title":"HIF1\u03b1 blockade reduces kidney injury in lupus nephritis","volume":"6","author":"Clarke","year":"2020","journal-title":"Nat Rev Nephrology."},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000896","article-title":"Calcinosis in systemic sclerosis","volume":"34","author":"Davuluri","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929289","article-title":"Intimate intertwining of the pathogenesis of hypoxia and systemic sclerosis: A transcriptome integration analysis","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00326","article-title":"Targeting hypoxia inducible factors-1\u03b1 As a novel therapy in fibrosis","volume":"8","author":"Xiong","year":"2017","journal-title":"Front Pharmacol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/art.23074","article-title":"Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheumatol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab532","article-title":"Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2\u03b1","volume":"61","author":"Ottria","year":"2022","journal-title":"Rheumatol (Oxford)."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez159","article-title":"Autophagy mediates 2-methoxyestradiol-inhibited scleroderma collagen synthesis and endothelial-to-mesenchymal transition induced by hypoxia","volume":"58","author":"Liu","year":"2019","journal-title":"Rheumatol (Oxford)."},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2014.0150","article-title":"Regulation of wound healing and fibrosis by hypoxia and hypoxia-inducible factor-1","volume":"37","author":"Ruthenborg","year":"2014","journal-title":"Mol Cells"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.636944","article-title":"Snail is a direct target of hypoxia-inducible factor 1\u03b1 (HIF1\u03b1) in hypoxia-induced endothelial to mesenchymal transition of human coronary endothelial cells","volume":"290","author":"Xu","year":"2015","journal-title":"J Biol Chem"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3193","article-title":"A hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis","volume":"21","author":"Choi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/j7ema8","article-title":"Exploration and validation of the hub genes involved in hypoxia-induced endothelial-mesenchymal transition of systemic sclerosis","volume":"41","author":"Li","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115282","article-title":"Further insight into systemic sclerosis from the vasculopathy perspective","volume":"166","author":"Ren","year":"2023","journal-title":"BioMed Pharmacother."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000898","article-title":"Role of cellular senescence in the pathogenesis of systemic sclerosis","volume":"34","author":"Tsou","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2015.1086432","article-title":"History of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis","volume":"45","author":"Mahmood","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab156","article-title":"Systemic sclerosis skin is a primed microenvironment for soft tissue calcification\u2014a hypothesis","volume":"60","author":"Burgess","year":"2021","journal-title":"Rheumatology."},{"key":"B179","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/23971983211053245","article-title":"Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis","volume":"7","author":"Valenzuela","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep151","article-title":"Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis","volume":"48","author":"Davies","year":"2009","journal-title":"Rheumatol (Oxford)."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2015.09.001","article-title":"Calcinosis cutis and calciphylaxis","volume":"106","author":"Jimenez-Gallo","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum Pathol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, classification and treatment of inflammatory myopathies","volume":"7","author":"Zong","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-512749","article-title":"Oxidative stress in angiogenesis and vascular disease","volume":"123","author":"Kim","year":"2014","journal-title":"Blood."},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.01.005","article-title":"Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors","volume":"20","author":"Probst-Cousin","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"B186","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-016-0308-5","article-title":"Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis","volume":"4","author":"Corinna","year":"2016","journal-title":"Acta neuropathologica Commun"},{"key":"B187","doi-asserted-by":"publisher","first-page":"8595","DOI":"10.1038\/s41598-017-09309-8","article-title":"Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis","volume":"7","author":"De Luna","year":"2017","journal-title":"Sci Rep"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.3.365","article-title":"Calcinosis cutis complicating adult-onset dermatomyositis","volume":"140","author":"Weinel","year":"2004","journal-title":"Arch Dermatol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab421","article-title":"Calcinosis in refractory dermatomyositis improves with tofacitinib monotherapy: a case series","volume":"60","author":"Shneyderman","year":"2021","journal-title":"Rheumatol (Oxford)."},{"key":"B190","doi-asserted-by":"publisher","first-page":"103061:103061","DOI":"10.1016\/j.jaut.2023.103061","article-title":"Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis","volume":"138","author":"Duvvuri B","year":"2020","journal-title":"J Autoimmun"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967304","article-title":"Composition and regulation of the immune microenvironment of salivary gland in Sjogren\u2019s syndrome","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5845849","article-title":"THU0230 HIF1A (RS11549465) and AKNA (RS10817595) gene polymorphisms are associated with primary sj\u00d6gren\u2019s syndrome","volume":"2017","author":"Hern\u00e1ndez-Molina","year":"2017","journal-title":"BioMed Res Int"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2898","article-title":"Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren\u2019s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18","volume":"181","author":"Sakai","year":"2008","journal-title":"J Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa695","article-title":"Increased expression of interleukin-21-inducible genes in minor salivary glands are associated with primary Sjogren\u2019s syndrome disease characteristics","volume":"60","author":"Chen","year":"2021","journal-title":"Rheumatol (Oxford)."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13351","article-title":"The HIF-1\u03b1 pathway plays a critical role in salivary gland development in ex vivo organ cultures","volume":"12","author":"Kimura","year":"2022","journal-title":"FEBS Open Bio."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.260","article-title":"Activation of HIF-1\u03b1(hypoxia inducible factor-1\u03b1) prevents dry eye-induced acinar cell death in the lacrimal gland","volume":"5","author":"Seo","year":"2014","journal-title":"Cell Death Dis"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2018.1518242","article-title":"Significance of M2 macrophage in tubulointerstitial disease secondary to primary Sjogren\u2019s disease","volume":"40","author":"Li","year":"2018","journal-title":"Ren Fail"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036144","article-title":"Network pharmacology identifies the inhibitory effect of Yiqiyangyinquyu prescription on salivary gland inflammation in Sjogren\u2019s syndrome","volume":"102","author":"Hong","year":"2023","journal-title":"Med (Baltimore)."},{"key":"B199","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9395","article-title":"Identification of pathways significantly associated with spondyloarthropathy\/ankylosing spondylitis using the sub\u2212pathway method","volume":"18","author":"Ding","year":"2018","journal-title":"Mol Med Rep"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861459","article-title":"Upregulated of ANXA3, SORL1, and neutrophils may be key factors in the progressionof ankylosing spondylitis","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood."},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13906","article-title":"Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats","volume":"51","author":"Hallak","year":"2024","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac240","article-title":"Leflunomide in combination with JAK-inhibitors in the treatment of rheumatoid arthritis: a case series","volume":"61","author":"Peter","year":"2022","journal-title":"Rheumatol (Oxford England)."},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2.4.347","article-title":"Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"2","author":"Fleischmann","year":"2005","journal-title":"Expert Opin Drug Safety."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.4103\/2045-9912.356475","article-title":"New scientific definitions: hyperbaric therapy and hyperbaric oxygen therapy","volume":"13","author":"HP","year":"2023","journal-title":"Med gas Res"},{"key":"B208","doi-asserted-by":"publisher","first-page":"pbae001","DOI":"10.1093\/pcmedi\/pbae001","article-title":"The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease","volume":"7","author":"Chen","year":"2024","journal-title":"Precis Clin Med"},{"key":"B209","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cellimm.2016.04.001","article-title":"Hypoxia-inducible factor 1 in autoimmune diseases","volume":"303","author":"Deng","year":"2016","journal-title":"Cell Immunol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.785586","article-title":"[amp]]alpha;-Mangostin alleviated HIF-1\u03b1-mediated angiogenesis in rats with adjuvant-induced arthritis by suppressing aerobic glycolysis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.061366","article-title":"Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy","volume":"77","author":"DeNiro","year":"2010","journal-title":"Mol Pharmacol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-023-00375-3","article-title":"Efficient targeting of HIF-1\u03b1 mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy","volume":"17","author":"Azar","year":"2023","journal-title":"J Biol Engineering."},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2012.674516","article-title":"Small-molecule inhibitors of the HIF pathway and synthetic lethal interactions","volume":"16","author":"JD","year":"2012","journal-title":"Expert Opin Ther targets."},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2021.1874345","article-title":"Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016\u20132020)","volume":"31","author":"Seung","year":"2021","journal-title":"Expert Opin Ther Patents."},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2016.1146252","article-title":"Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)","volume":"26","author":"Seung","year":"2016","journal-title":"Expert Opin Ther patents."},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01313","article-title":"Discovery of novel aryl carboxamide derivatives as hypoxia-inducible factor 1\u03b1 Signaling inhibitors with potent activities of anticancer metastasis","volume":"62","author":"Liu M","year":"2019","journal-title":"J medicinal Chem"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1007\/S10753-023-01878-3","article-title":"Novel HIF-1\u03b1 Inhibitor AMSP-30m mitigates the pathogenic cellular behaviors of hypoxia-stimulated fibroblast-like synoviocytes and alleviates collagen-induced arthritis in rats via inhibiting sonic hedgehog pathway","volume":"46","author":"Li","year":"2023","journal-title":"Inflammation."},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2092054","article-title":"Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study","volume":"63","author":"Zejin","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.2174\/1573397114666180717145745","article-title":"Metformin one in a million efficient medicines for rheumatoid arthritis complications: inflammation, osteoblastogenesis, cardiovascular disease, Malignancies","volume":"15","author":"Rajaei E","year":"2019","journal-title":"Curr Rheumatol Rev"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53755-8","article-title":"Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1\/S-phase growth arrest in T lymphocytes","volume":"268","author":"Morice","year":"1993","journal-title":"J Biol Chem"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm652","article-title":"Sirolimus in renal transplantation","volume":"22","author":"Morath","year":"2007","journal-title":"Nephrol Dialysis Transplant"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010099","article-title":"Association between immunosuppressive therapy utilized in the treatment of autoimmune disease or transplant and cancer progression","volume":"11","author":"Amanda","year":"2022","journal-title":"Biomedicines."},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3321","article-title":"Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study","volume":"27","author":"Maristella","year":"2018","journal-title":"Protein science: Publ Protein Society."},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.588913","article-title":"Interactions of FK506 and rapamycin with FK506 binding protein 12 in opportunistic human fungal pathogens","volume":"7","author":"Sandeep","year":"2020","journal-title":"Front Mol biosciences."},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2018.10.108","article-title":"DINP aggravates autoimmune thyroid disease through activation of the Akt\/mTOR pathway and suppression of autophagy in Wistar rats","volume":"245","author":"Duan","year":"2019","journal-title":"Environ Pollution."},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.5.2775","article-title":"Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation","volume":"162","author":"Anergy","year":"1999","journal-title":"J Immunol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.10.5636","article-title":"Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness","volume":"167","author":"Vanasek","year":"2001","journal-title":"J Immunol (Baltimore Md: 1950)."},{"key":"B228","doi-asserted-by":"publisher","first-page":"0006","DOI":"10.1182\/blood.V130.Suppl_1.4728.4728","article-title":"Sirolimus is effective in refractory immune thrombocytopenia: results of an open-label prospective multicenter trial in China","volume":"130","author":"Lei","year":"2017","journal-title":"BLOOD."},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25119","article-title":"Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil","volume":"93","author":"Maurizio","year":"2018","journal-title":"Am J hematology."},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0178","article-title":"FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma","volume":"15","author":"KV","year":"2010","journal-title":"oncologist."},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxac033","article-title":"A mechanistic target of rapamycin (mTOR) inhibitor, everolimus safely ameliorated lupus nephritis in a patient complicated with tuberous sclerosis","volume":"7","author":"Yasutaka","year":"2022","journal-title":"Modern Rheumatol Case Rep"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy148.069","article-title":"Actr-36. A single arm phase 2 study of the dual mtorc1\/mtorc2 inhibitor vistusertib provided on an intermittent schedule for neurofibromatosis 2 patients with progressive or symptomatic meningiomas","volume":"20","author":"Plotkin","year":"2018","journal-title":"Neuro-Oncology"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8808","article-title":"Randomized open-label phase II trial of apitolisib (GDC-0980), a novel inhibitor of the PI3K\/mammalian target of rapamycin pathway, versus everolimus in patients with metastatic renal cell carcinoma","volume":"34","author":"Thomas","year":"2016","journal-title":"J Clin oncology: Off J Am Soc Clin Oncol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109241","article-title":"Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K\/AKT\/mTOR signaling pathway","volume":"112","author":"Junjie","year":"2022","journal-title":"Int Immunopharmacology."},{"key":"B235","doi-asserted-by":"publisher","first-page":"3643265","DOI":"10.1155\/2022\/3643265","article-title":"Baicalein induces apoptosis of rheumatoid arthritis synovial fibroblasts through inactivation of the PI3K\/akt\/mTOR pathway","volume":"2022","author":"Xue","year":"2022","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114550","article-title":"Retraction notice to \u201cEffects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K\/AKT\/mTOR signaling pathway in rat models with rheumatoid arthritis\u201d [Biomed","volume":"162","author":"FaBo","year":"2023","journal-title":"Pharmacother. 102 (2018) 1209-1220]. Biomedicine pharmacotherapy = Biomedecine pharmacotherapie."},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111727","article-title":"Phloridzin reduces synovial hyperplasia and inflammation in rheumatoid arthritis rat by modulating mTOR pathway","volume":"133","author":"Wang","year":"2024","journal-title":"Int Immunopharmacology."},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713162","article-title":"Effect of antioxidant supplementation on NET formation induced by LPS in vitro; the roles of vitamins E and C, glutathione, and N-acetyl cysteine","volume":"24","author":"Germ\u00e1n","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12902","article-title":"Reduction in migraine and headache frequency and intensity with combined antioxidant prophylaxis (N-acetylcysteine, vitamin E, and vitamin C): A randomized sham-controlled pilot study","volume":"20","author":"John","year":"2020","journal-title":"Pain practice: Off J World Institute Pain."},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1002\/MED.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Thomas","year":"2021","journal-title":"Medicinal Res Rev"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2015.09.017","article-title":"Dietary extra virgin olive oil attenuates kidney injury in pristane-induced SLE model via activation of HO-1\/Nrf-2 antioxidant pathway and suppression of JAK\/STAT, NF-\u03baB and MAPK activation","volume":"27","author":"Aparicio-Soto","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2024.103017","article-title":"Evidence of the interactions between immunosuppressive drugs used in autoimmune rheumatic diseases and Chinese herbal medicine: A scoping review","volume":"80","author":"Woon","year":"2024","journal-title":"Complementary Therapies Med"},{"key":"B243","doi-asserted-by":"publisher","first-page":"10781552231167824","DOI":"10.1177\/10781552231167824","article-title":"Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review","volume":"30","author":"WSC","year":"2023","journal-title":"J Oncol Pharm practice: Off Publ Int Soc Oncol Pharm Practitioners."},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/J.REVMED.2022.03.343","article-title":"Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases","volume":"43","author":"Djabarouti","year":"2022","journal-title":"La Rev medecine interne."},{"key":"B245","article-title":"Effects of dihydroartemisinin on collagen II-induced arthritis in rats model","volume":"43","author":"Yan-yan","year":"2012","journal-title":"J Of Sichuan Univ (Medical Sciences)."},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1002\/art.30392","article-title":"Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses","volume":"63","author":"Li-Fei","year":"2011","journal-title":"Arthritis rheumatism."},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.02.056","article-title":"Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats","volume":"70","author":"Bai","year":"2019","journal-title":"Int Immunopharmacology."},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1080\/10520295.2019.1647457","article-title":"Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats","volume":"95","author":"Akta\u015f I","year":"2020","journal-title":"Biotechnic histochemistry: Off Publ Biol Stain Commission."},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201500109R","article-title":"Artemisitene activates the Nrf2-dependent antioxidant response and protects against bleomycin-induced lung injury","volume":"30","author":"Chen W","year":"2016","journal-title":"FASEB journal: Off Publ Fed Am Societies Exp Biol"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken468","article-title":"Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis","volume":"48","author":"Kawai","year":"2009","journal-title":"Rheumatol (Oxford England)"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1590334","article-title":"Tocilizumab for the treatment of adult-onset Still\u2019s disease","volume":"19","author":"Casta\u00f1eda","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B252","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Ann rheumatic diseases."},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098187","article-title":"Focus on anti-tumour necrosis factor (TNF)-\u03b1-related autoimmune diseases","volume":"24","author":"Riccardo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 Inhibitors in therapeutics","volume":"22","author":"Danin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1821","article-title":"Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy","volume":"6","author":"OC","year":"2006","journal-title":"Nat Rev Cancer."},{"key":"B256","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2332\/allergolint.54.191","article-title":"Anti-TNF biological agents in rheumatoid arthritis and other inflammatory diseases","volume":"54","author":"Takeuchi","year":"2005","journal-title":"Allergology Int"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.09.758","article-title":"EE516 budget-impact model of adalimumab-biosimilar sandoz in the management of autoimmune diseases in the middle east","volume":"25","author":"Alnaqbi","year":"2022","journal-title":"Value Health"},{"key":"B258","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2004.11.001","article-title":"Tumor necrosis factor, cancer and anticancer therapy","volume":"16","author":"Simone","year":"2005","journal-title":"Cytokine Growth factor Rev"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403852","article-title":"Therapeutic renaissance of thalidomide in the treatment of haematological Malignancies","volume":"19","author":"Ribatti","year":"2005","journal-title":"Leukemia"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20035","article-title":"Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice","volume":"39","author":"Narci","year":"2004","journal-title":"Hepatol (Baltimore Md)."},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic Malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann rheumatic diseases."},{"key":"B262","doi-asserted-by":"publisher","first-page":"7","DOI":"10.18553\/jmcp.2007.13.s1.7","article-title":"The comparative safety and effectiveness of TNF-alpha antagonists","volume":"13","author":"Solomon","year":"2007","journal-title":"J Managed Care Pharm"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952398","article-title":"Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases","volume":"13","author":"Lu","year":"2022","journal-title":"Front Immunol"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06409-6","article-title":"Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells","volume":"620","author":"SL","year":"2023","journal-title":"Nature."},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096282480240105071638","article-title":"Cancer and autoimmune diseases as two sides of chronic inflammation - and the method of therapy","volume":"24","author":"Rogovskii","year":"2024","journal-title":"Curr Cancer Drug targets."},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2016.04.008","article-title":"Immune modulation for autoimmune disorders: evolution of therapeutics","volume":"53","author":"Liebman","year":"2016","journal-title":"Semin Hematology."},{"key":"B267","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nm.2625","article-title":"Optimization of current and future therapy for autoimmune diseases","volume":"18","author":"Steinman L","year":"2012","journal-title":"Nat Med"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.202149675","article-title":"Targeting B cells and plasma cells in autoimmune diseases: from established treatments to novel therapeutic approaches","volume":"53","author":"Ana","year":"2022","journal-title":"Eur J Immunol"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.103235","article-title":"The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review","volume":"44","author":"Chandrashekara","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214918","article-title":"Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis","volume":"78","author":"Aletaha","year":"2019","journal-title":"Ann Rheumatic Diseases."},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.2174\/1389450123666220111114649","article-title":"Directing hypoxic tumor microenvironment and HIF to illuminate cancer immunotherapy\u2019s existing prospects and challenges in drug targets","volume":"23","author":"Kumar","year":"2022","journal-title":"Curr Drug Targets"},{"key":"B272","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2019.05.021","article-title":"Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints","volume":"458","author":"Lequeux","year":"2019","journal-title":"Cancer Letters."},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.04.009","article-title":"Targeting the HIF pathway in inflammation and immunity","volume":"13","author":"Scholz","year":"2013","journal-title":"Curr Opin Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1435306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T06:11:46Z","timestamp":1730959906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1435306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":273,"alternative-id":["10.3389\/fimmu.2024.1435306"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1435306","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"article-number":"1435306"}}